EcoDrugPlus

Adrenoceptor Alpha 2c

Ensembl ID : ENSOMYG00000072596
Gene Symbol: ADRA2C
1 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOMYG00000030102
Gene Symbol: ADRA2C
1 Cross references
151 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOMYG00000005869
Gene Symbol: ADRA2C
1 Cross references
151 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSOMYG00000058892
Gene Symbol: ADRB2A
1 Cross references
190 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSOMYG00000012647
Gene Symbol: ADRB2B
1 Cross references
186 Possible Orthologues:

Adrenoceptor Beta 2, Surface B

Ensembl ID : ENSOMYG00000017194
Gene Symbol: ADRB2B
1 Cross references
186 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSOMYG00000008954
Gene Symbol: ADRB3A
1 Cross references
191 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSOMYG00000038741
Gene Symbol: ADRB3B
1 Cross references
144 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSOMYG00000013473
Gene Symbol: GAA
1 Cross references
226 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSOMYG00000016003
Gene Symbol: GAA
1 Cross references
226 Possible Orthologues:

Alpha-1d Adrenoreceptor

Ensembl ID : ENSOMYG00000015475
Gene Symbol: ADRA1B
2 Cross references
188 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSOMYG00000019814
Gene Symbol: AOC1
2 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).